FeesSafety
Pluang+

Experian lowers revenue growth forecast due to weaker US mortgage market but retains positive broker ratings

Market News
20 Nov 2026, 02:14 WIB
Proactive Investors
View Source
Bullish
Experian lowers revenue growth forecast due to weaker US mortgage market but retains positive broker ratings

Experian has reduced its full-year organic revenue growth forecast to 6-7% from 6-8%, citing expected declines in US mortgage volumes driven by higher interest rates. Despite this, Deutsche Bank and RBC maintain positive outlooks, rating the shares as 'buy' and 'outperform' respectively, with price targets of 3,500p and 3,300p. The company expects benchmark earnings per share growth of about 12%, with Deutsche Bank forecasting slightly higher at 13%. RBC noted regional differences in consumer services, with strong growth in Latin America but a decline in North America, which is expected to improve in the next financial year.

Experian's outlook update comes with Pluang's Financials sector data as context. Of 142 priced US Financials stocks on Pluang, 14 rose and 128 fell today. LU (Lufax Holding Ltd) traded at USD 6.09 with a 4.09% decline and 100% sell order activity as of Nov 20, 2026 06:41 WIB.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App